NCT03722537 Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
| NCT ID | NCT03722537 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Basal Joint Arthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2019-11-14 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2019-11-14 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a study comparing the current standard of care surgical treatment to a newer surgical procedure involving the implantation of osteochondral allograft at the base of the thumb. Patients will be followed at 1, 3, 6 months and 1 year post-operatively.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Indicated for operative management of basal joint arthritis Exclusion Criteria: * Pregnant women/fetuses/neonates, prisoners * Previously operated on for treatment of basal joint arthritis
Contact & Investigator
Melvin P Rosenwasser, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT03722537 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Basal Joint Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03722537 currently recruiting?
Yes, NCT03722537 is actively recruiting participants. Contact the research team at mpr2@cumc.columbia.edu for enrollment information.
Where is the NCT03722537 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT03722537 clinical trial?
NCT03722537 is sponsored by Columbia University. The principal investigator is Melvin P Rosenwasser, MD at Columbia University. The trial plans to enroll 200 participants.